CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for Tough-to-Treat kidney cancer
Disease control CompletedThis early-stage study tested a new drug called ARO-HIF2 in 26 patients with advanced kidney cancer that had stopped responding to standard treatments. The main goals were to find a safe dose and see how the body processes the drug. Researchers also looked for early signs that th…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Drug combo shrinks tumors, saves kidneys in High-Risk cancer
Disease control CompletedThis study tested whether giving two drugs, cadonilimab and lenvatinib, before surgery could shrink high-risk kidney tumors enough to allow for a kidney-sparing operation. It involved 39 patients with localized kidney cancer for whom surgery was difficult. The goal was to see if …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
CRISPR-Edited immune cells battle tough cancers in new trial
Disease control CompletedThis study tested a new type of cell therapy called CTX131 for adults with advanced solid tumors that have returned or stopped responding to standard treatments. CTX131 uses a patient's own immune cells that are genetically modified in a lab to better target and fight cancer cell…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control CompletedThis was a first-in-human study to test the safety and early effectiveness of a new drug called CHS-388 for people with advanced solid tumors. The trial enrolled 145 adults with cancers like kidney, liver, and lung cancer that had progressed after standard treatments. Researchers…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC